[Is tissue typing is unnecessary for kidney transplantation?]. 2005

Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
December 1985, Kidney international. Supplement,
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
October 2019, Nephrology (Carlton, Vic.),
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
November 1971, Nederlands tijdschrift voor geneeskunde,
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
August 1963, British medical journal,
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
February 1987, Transplantation proceedings,
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
May 1972, The Journal of urology,
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
July 1970, The New Zealand medical journal,
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
June 1993, Transplantation proceedings,
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
October 1970, Pediatrics,
Lauri Kyllönen, and Kaija Salmela, and Irma Matinlauri
March 1972, Proceedings of the Royal Society of Medicine,
Copied contents to your clipboard!